CoChat

In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants

Ramchandani, M., Robinson, D. · 1998 · Journal of Controlled Release

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Poly(lactides-co-glycolides) [PLGA] are widely investigated biodegradable polymers and are extensively used in several biomaterials applications as well as drug delivery systems. These polymers degrade by bulk hydrolysis of ester bonds and break down into their constituent monomers, lactic and glycolic acids which are excreted from the body. The purpose of this investigation was to develop and characterize a biodegradable, implantable delivery system containing ciprofloxacin hydrochloride (HCl) for the localized treatment of osteomyelitis and to study the extent of drug penetration from the site of implantation into the bone. Osteomyelitis is an inflammatory bone disease caused by pyogenic bacteria and involves the medullary cavity, cortex and periosteum. The advantages of localized biodegradable therapy include high, local antibiotic concentration at the site of infection, as well as, obviation of the need for removal of the implant after treatment. PLGA 50:50 implants were compressed from microcapsules prepared by nonsolvent-induced phase-separation using two solvent-nonsolvent systems, viz., methylene chloride-hexane (non-polar) and acetone-phosphate buffer (polar). In vitro dissolution studies were performed to study the effect of manufacturing procedure, drug loading and pH on the release of ciprofloxacin HCl. The extent of penetration of the drug from the site of implantation was studied using a rabbit model. The results of in vitro studies illustrated that drug release…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0168-3659(97)00113-2

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 18 references

Research works printed but not linked: 1

  1. K. Klemm, Septopal - A new way of local antibiotic therapy, in: J.G. van Rens, F.H. Kayser (Eds.), Local Antibiotic Treatment in Osteomyelitis and Soft-Tissue Infections, Excerptia Medica, Amsterdam, 1981, pp. 24–37.

Cited by

See all 195

Metadata

Authors
Ramchandani, M., & Robinson, D.
Affiliations
  • Integra LifeSciences (United States) (US)
  • Nebraska Medical Center (US)
Corresponding author
Ramchandani, M.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
1998-07
Volume
54
Issue
2
Pages
167-175
ISSN
0168-3659 (ISSN-L)
OpenAlex
W1991976751
Cited by
195
References
18
Citations by year
2026: 1 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 9 · 2019: 6 · 2018: 9 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 15 · 2013: 7 · 2012: 11
FWCI
3.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
Keywords
PLGA implants, poly(lactic-co-glycolic acid), controlled drug release, osteomyelitis, biodegradable drug delivery, microcapsules, non-solvent induced phase separation, implant resorption, drug loading, biphasic release
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Anti-Infective Agents, Biocompatible Materials, Capsules, Ciprofloxacin, Disease Models, Animal, Drug Carriers, Drug Implants, Femur, Osteomyelitis, Polyglycolic Acid, Polymers, Rabbits, Time Factors, Lactic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. https://app.cochat.ai/papers/10.1016/s0168-3659(97)00113-2
The paper
Ramchandani, M., & Robinson, D. (1998). In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. Journal of Controlled Release. https://doi.org/10.1016/s0168-3659(97)00113-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.